Effects of Combinations of Methylxanthines and Adenosine Analogs on Locomotor Activity in Control and Chronic

Olga Nikodijević1, Kenneth A Jacobson1, John W Daly1

  • 1Laboratory of Bioorganic Chemistry, National Institute of Diabetes, Digestive, and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.

Drug Development Research
|January 22, 2024
PubMed

Insights

Chronic caffeine ingestion in mice leads to lasting changes in activity and responses to caffeine and related compounds. These mice show altered sensitivity to adenosine receptor agonists, impacting their overall behavior.

Area of Science:

  • Neuropharmacology
  • Behavioral Neuroscience

Background:

  • Chronic caffeine ingestion (CCI) alters mammalian responses to stimulants and depressants.
  • Adenosine receptors play a crucial role in modulating locomotor activity and caffeine's effects.

Purpose of the Study:

  • To investigate the long-term effects of chronic caffeine ingestion on locomotor activity and sensitivity to various xanthines and adenosine analogs in mice.
  • To characterize the changes in dose-response curves for caffeine, selective A1 and A2 adenosine receptor agonists, and their combinations following CCI.

Main Methods:

  • Male NIH Swiss strain mice underwent chronic caffeine ingestion.
  • Locomotor activity was measured in response to caffeine, other xanthines (CPT, DMPX), and adenosine analogs (CHA, APEC).
  • Dose-response curves were analyzed to assess shifts and alterations in drug effects.

Main Results:

  • CCI resulted in a prolonged reduction in locomotor activity and left-shifted dose-response curves for caffeine, CPT, and DMPX.
  • Mice exhibited increased sensitivity to the depressant effects of A1, A2, and mixed A1/A2 adenosine receptor agonists after CCI.
  • The phasic depressant-stimulatory-depressant effects of agonists, and synergistic effects of agonist combinations, were reduced or absent post-CCI.

Conclusions:

  • Chronic caffeine ingestion induces significant and lasting neuroadaptations in mice, affecting locomotor activity and adenosine receptor signaling.
  • These adaptations include altered sensitivity to adenosine agonists, suggesting a complex interplay between caffeine and the adenosine system.
  • The findings highlight the profound impact of sustained caffeine exposure on central nervous system function and drug response.

Related Concept Videos

Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
717
Antiasthma Drugs: Methylxanthines01:24

Antiasthma Drugs: Methylxanthines

Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
231
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.0K
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
1.5K
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K